(Q73852591)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

A M Hujer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K M Hujer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R A Bonomo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

number of pages

14

1 reference

Biochimica et Biophysica Acta

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

1547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

37-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

A functional classification scheme for beta-lactamases and its correlation with molecular structure

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

The structure of β-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

A standard numbering scheme for the class A beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Catalytic properties of class A beta-lactamases: efficiency and diversity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Structure of the SHV-1 beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Beta-lactamase TEM1 of E. coli. Crystal structure determination at 2.5 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Amino acid sequence determinants of beta-lactamase structure and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

The role of residue 238 of TEM-1 beta-lactamase in the hydrolysis of extended-spectrum antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta-lactamase TEM-1 and the G238S mutant.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Structural basis for the inactivation of the P54 mutant of beta-lactamase from Staphylococcus aureus PC1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Complementary roles of mutations at positions 69 and 242 in a class A beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

OHIO-1 beta-lactamase mutants: the Arg244Ser mutant and resistance to beta-lactams and beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Catalytic mechanism of active-site serine beta-lactamases: role of the conserved hydroxy group of the Lys-Thr(Ser)-Gly triad

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

Site-directed mutagenesis of .beta.-lactamase leading to accumulation of a catalytic intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

A catalytically-impaired class A beta-lactamase: 2 A crystal structure and kinetics of the Bacillus licheniformis E166A mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900164-9

7 January 2021

10.1016/S0167-4838(01)00164-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11343789%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference